MYELOMA, MULTIPLE

This early-stage trial is testing a new oral medication called KTX-1001 for adults with advanced multiple myeloma that has returned or stopped responding to standard treatments. The study aims to find the safest and most effective dose and see if the drug helps control the cancer…

This study is testing whether a two-drug combination (belantamab mafodotin plus lenalidomide) given as maintenance therapy after a patient's own stem cell transplant can help eliminate any remaining, hard-to-detect cancer cells in people with newly diagnosed multiple myeloma. The…

This study is testing whether patients with multiple myeloma can safely give themselves their standard chemotherapy injections at home instead of traveling to a hospital. Researchers want to see if home administration works well, is safe, and improves quality of life for patients…

This study is testing whether patients with hard-to-treat multiple myeloma who respond well to the drug teclistamab can safely stop taking it for a while, instead of continuing it forever. The goal is to see if taking a break from treatment works as well as continuous therapy at …

This study is testing whether a smart scale that patients use at home can help doctors remotely monitor adults with lymphoma or myeloma who are getting chemotherapy. For about 7 weeks, 30 patients will weigh themselves daily. The scale sends data to the medical team, who can get …

This early-stage trial is testing the safety of a new gene therapy called KLN-1010 for people with multiple myeloma that has returned after multiple treatments. The therapy aims to reprogram the patient's own immune cells inside their body to attack cancer cells. Researchers will…

This small pilot study is testing whether two different emotional support programs are practical and acceptable for people recently diagnosed with advanced cancer. The programs use techniques like cognitive behavioral therapy, hypnosis, and positive psychology to help patients be…

This study aims to better understand various blood cancers by analyzing patient samples using multiple advanced laboratory techniques. Researchers will examine bone marrow, blood, and tissue samples from 1,040 patients across Italy, both from past collections and new participants…

This study is collecting information about how patients with blood cancers and disorders respond to stem cell transplants in the high-altitude Tibetan region. Researchers are enrolling 1000 patients and their donors to track treatment patterns, recovery times, survival rates, and…